More Insights Revealed At J.P. Morgan Conference

Further Off-Patent Industry News From Firms In San Francisco

 
• By Dean Rudge, Urtė Fultinavičiūtė, Dave Wallace, and Adam Zamecnik

In the aftermath of last week’s J.P. Morgan Healthcare Conference in San Francisco, Generics Bulletin’s editorial team brings you additional coverage of items of interest for the global generics and biosimilars industry.

Numerous firms made key announcements at the J.P. Morgan conference (Shutterstock)

More from Strategy

More from Biosimilars